Life Care Center Of North Glendale | |
13620 North 55th Avenue, Glendale, Arizona 85304 | |
(602) 843-8433 | |
Name | Life Care Center Of North Glendale |
---|---|
Location | 13620 North 55th Avenue, Glendale, Arizona |
Certified By | Medicare and Medicaid |
No. of Certified Beds | 223 |
Occupancy Rate | 51.17% |
Medicare ID (CCN) | 035126 |
Legal Business Name | Glendale Medical Investors Lp |
Ownership Type | For Profit - Corporation |
NPI Number | 1376580357 |
Organization Name | GLENDALE MEDICAL INVESTORS LIMITED PARTNERSHIP |
Doing Business As | LIFE CARE CENTER OF NORTH GLENDALE |
Address | 13620 N 55th Ave, Glendale, AZ 85304 |
Phone Number | 602-843-8433 |
News Archive
AmpliPhi BioSciences Corp. (OTC: APHB) ("AmpliPhi"), the leader in the development of bacteriophage-based antibacterial therapies to treat drug resistant bacterial infections, yesterday presented data relating to the use of bacteriophages in the treatment of Pseudomonas aeruginosa (P. aeruginosa) at the 20th Biennial Evergreen International Phage Meeting held in Olympia, Washington, USA. P. aeruginosa is the major cause of lung infections in cystic fibrosis (CF) patients.
The Mass Adult Day Health Alliance, the largest provider of adult day health programs for elders in Massachusetts, announced today that it has been acquired by Civitis Solutions Inc., a national organization of local health and human services providers that markets its services under the name The MENTOR Network.
Health experts say that in order to gain any benefit from exercise people need to get in a sweat.
The U.S. Food and Drug Administration today approved Bosulif (bosutinib) to treat chronic myelogenous leukemia (CML), a blood and bone marrow disease that usually affects older adults.
Silicon Valley Bank, financial partner to technology and life science companies of all sizes worldwide, added a new $10 million term loan to existing credit facilities for Solta Medical, a global leader in the medical aesthetics market. The additional term loan increases Solta Medical's credit facilities with Silicon Valley Bank to a total of $22 million. Solta Medical would expect to use the additional facility to pursue strategic initiatives.
› Verified 9 days ago
Ratings from Surveys (Inspections): | |
Ratings from Quality Measures: | |
Ratings from Staffing Data: | |
Overall Rating: |
---|
News Archive
AmpliPhi BioSciences Corp. (OTC: APHB) ("AmpliPhi"), the leader in the development of bacteriophage-based antibacterial therapies to treat drug resistant bacterial infections, yesterday presented data relating to the use of bacteriophages in the treatment of Pseudomonas aeruginosa (P. aeruginosa) at the 20th Biennial Evergreen International Phage Meeting held in Olympia, Washington, USA. P. aeruginosa is the major cause of lung infections in cystic fibrosis (CF) patients.
The Mass Adult Day Health Alliance, the largest provider of adult day health programs for elders in Massachusetts, announced today that it has been acquired by Civitis Solutions Inc., a national organization of local health and human services providers that markets its services under the name The MENTOR Network.
Health experts say that in order to gain any benefit from exercise people need to get in a sweat.
The U.S. Food and Drug Administration today approved Bosulif (bosutinib) to treat chronic myelogenous leukemia (CML), a blood and bone marrow disease that usually affects older adults.
Silicon Valley Bank, financial partner to technology and life science companies of all sizes worldwide, added a new $10 million term loan to existing credit facilities for Solta Medical, a global leader in the medical aesthetics market. The additional term loan increases Solta Medical's credit facilities with Silicon Valley Bank to a total of $22 million. Solta Medical would expect to use the additional facility to pursue strategic initiatives.
› Verified 9 days ago
Number of Facility Reported Incidents | 0 |
Number of Substantiated Complaints | 0 |
Number of Fines | 1 |
Total Amount of Fines in Dollars | $8294 |
Number of Payment Denials | 0 |
Total Number of Penalties | 1 |
Experience Measure | Provider | National Avg. |
---|---|---|
Percentage of long-stay residents whose need for help with daily activities has increased | 14.77 | 14.46 |
Percentage of long-stay residents who lose too much weight | 11.2 | 5.51 |
Percentage of low risk long-stay residents who lose control of their bowels or bladder | 73.45 | 48.41 |
Percentage of long-stay residents with a catheter inserted and left in their bladder | 1.66 | 1.79 |
Percentage of long-stay residents with a urinary tract infection | 3.37 | 2.65 |
Percentage of long-stay residents who have depressive symptoms | 0.28 | 5.05 |
Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
Percentage of long-stay residents experiencing one or more falls with major injury | 1.55 | 3.36 |
Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 93.56 | 93.87 |
Percentage of long-stay residents who received an antipsychotic medication | 10.74 | 14.2 |
Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 97.25 | 83.88 |
Percentage of short-stay residents who newly received an antipsychotic medication | 0.9 | 1.79 |
Percentage of long-stay residents whose ability to move independently worsened | 37.41 | 17.09 |
Percentage of long-stay residents who received an antianxiety or hypnotic medication | 27.86 | 19.7 |
Percentage of high risk long-stay residents with pressure ulcers | 12.57 | 7.32 |
Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 99.31 | 95.98 |
Percentage of short-stay residents who made improvements in function | 61.81 | 67.99 |
Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 96.52 | 82.93 |
News Archive
AmpliPhi BioSciences Corp. (OTC: APHB) ("AmpliPhi"), the leader in the development of bacteriophage-based antibacterial therapies to treat drug resistant bacterial infections, yesterday presented data relating to the use of bacteriophages in the treatment of Pseudomonas aeruginosa (P. aeruginosa) at the 20th Biennial Evergreen International Phage Meeting held in Olympia, Washington, USA. P. aeruginosa is the major cause of lung infections in cystic fibrosis (CF) patients.
The Mass Adult Day Health Alliance, the largest provider of adult day health programs for elders in Massachusetts, announced today that it has been acquired by Civitis Solutions Inc., a national organization of local health and human services providers that markets its services under the name The MENTOR Network.
Health experts say that in order to gain any benefit from exercise people need to get in a sweat.
The U.S. Food and Drug Administration today approved Bosulif (bosutinib) to treat chronic myelogenous leukemia (CML), a blood and bone marrow disease that usually affects older adults.
Silicon Valley Bank, financial partner to technology and life science companies of all sizes worldwide, added a new $10 million term loan to existing credit facilities for Solta Medical, a global leader in the medical aesthetics market. The additional term loan increases Solta Medical's credit facilities with Silicon Valley Bank to a total of $22 million. Solta Medical would expect to use the additional facility to pursue strategic initiatives.
› Verified 9 days ago
Bella Vita Health And Rehabilitation Center Location: 5125 North 58th Avenue, Glendale, Arizona 85301 Phone: (623) 931-5800 | |
Life Care Center Of North Glendale Location: 13620 North 55th Avenue, Glendale, Arizona 85304 Phone: (602) 843-8433 | |
Providence Place At Glencroft Location: 8641 North 67th Ave, Glendale, Arizona 85302 Phone: (623) 939-9475 | |
Horizon Post Acute And Rehabilitation Center Location: 4704 West Diana Avenue, Glendale, Arizona 85302 Phone: (623) 247-3949 | |
Advanced Health Care Of Glendale Location: 16825 North 63rd Avenue, Glendale, Arizona 85306 Phone: (602) 732-3400 | |
Center At Arrowhead, Llc Location: 7201 W Camino San Xavier Ave, Glendale, Arizona 85308 Phone: (623) 773-6100 |